<atl>Impact of iKRAS/i codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumab</atl>

Journal:
Journal of the National Cancer Institute
Published:
DOI:
10.1093/jnci/djaf385
Affiliations:
4
Authors:
14
Go to article
Institutions Authors Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)
8.500000
 0.61
Tempus, United States of America (USA)
4.000000
 0.29
IRCCS Istituto Oncologico Veneto (IOV), Italy
1.500000
 0.11
Interested in Oncology and Carcinogenesis?